Physician profile
Norbert C Brehm
NPI 1699761213
$2,624.05
in general payments reported to CMS, 2019-2025
22 companies · $338 in 2025
The $338 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $126 · 2021: $830 · 2022: $376 · 2023: $360 · 2024: $444 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $925 · Education: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $924.74 |
| Education | $217.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $810.71 | 2019-2024 | Myrbetriq |
| Abbvie INC. | $446.82 | 2023-2025 | Botox |
| Teleflex LLC | $400.38 | 2021 | |
| Urovant Sciences INC | $113.08 | 2021 | |
| Agiliti Surgical, INC. | $97.32 | 2025 | Sonablate Hifu, Koelis Trinity Mri/US Fusion |
| Myovant Sciences INC. | $86.21 | 2021-2022 | |
| Allergan, INC. | $75.37 | 2019 | |
| Endo Pharmaceuticals INC. | $73.75 | 2019-2021 | |
| Janssen Biotech, INC. | $71.30 | 2019-2024 | Erleada, Akeega |
| Boston Scientific Corporation | $59.18 | 2020-2024 | |
| Urogen Pharma, INC. | $48.76 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $48.54 | 2023-2024 | Orgovyx |
| Merck Sharp & Dohme LLC | $44.00 | 2022 | |
| Antares Pharma, INC. | $43.78 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $37.34 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $35.06 | 2025 | Imfinzi |
| Medtronic, INC. | $33.25 | 2023 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $24.76 | 2023 | |
| Dendreon Pharmaceuticals LLC | $24.27 | 2019 | |
| Myriad Genetic Laboratories, INC. | $21.75 | 2025 | Prolaris |
| Tolmar Pharmaceuticals, INC. | $17.77 | 2021 | |
| Healthtronics Stone Solutions, LLC | $10.65 | 2024 | Dornier Medtech |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norbert Brehm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.